Trial Condition(s):

Contraception, Ovulation inhibition, Contraceptives, Oral

Study to evaluate efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 21-day regimen

Bayer Identifier:

90809

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
516
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Yasminelle (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design